Abstract:Major 5'-terminally deleted (5'TD) RNA forms of group-B coxsackievirus (CVB-5'TD) has been associated with myocarditis in both mice and humans. Although it is known that interferon-β (IFN-β) signaling is critical for an efficient innate immune response against CVB-induced myocarditis, the link between CVB-5'TD RNA forms and type I IFN signaling in cardiomyocytes remains to be explored. In a mouse model of CVB3/28-induced myocarditis, major early-emerging forms of CVB-5'TD RNA have been characterized as replicative viral populations that impair IFN-β production in the heart. Synthetic CVB3/28 RNA forms mimicking each of these major 5'TD virus populations were transfected in mice and have been shown to modulate innate immune responses in the heart and to induce myocarditis in mice. Remarkably, transfection of synthetic viral RNA with deletions in the secondary structures of the 5'-terminal CVB3 RNA domain I, modifying stem-loops "b", "c" or "d", were found to impair IFN-β production in human cardiomyocytes. In addition, the activation of innate immune response by Poly(I:C), was found to restore IFN-β production and to reduce the burden of CVB-5'TD RNA-forms in cardiac tissues, thereby reducing the mortality rate of infected mice. Overall, our results indicate that major early-emerging CVB3 populations deleted in the domain I of genomic RNA, in the 5' noncoding region, modulate the activation of the type I IFN pathway in cardiomyocytes and induce myocarditis in mice. These findings shed new light on the role of replicative CVB-5'TD RNA forms as key pathophysiological factors in CVB-induced human myocarditis. Myocarditis is an inflammatory disease of the heart. Viruses or post-viral immune mediated response are the main causes of myocarditis. Human group B enteroviruses, specifically Coxsackievirus B3 (CVB3), are common infectious causes of acute myocarditis in the young. Early emergence and maintenance of major 5'terminally deleted RNA forms of CVB have been associated with acute and chronic myocarditis in both mice and humans. To achieve viral genome maintenance in the cardiac cells, viruses could modulate innate immunity activation. Here, we report on major early-emerging CVB3 populations deleted in the 5'non-coding region of viral genomic RNA that modulate the activation of the type I interferon pathway in cardiomyocytes and cause myocarditis in mice. Activating the innate immune sensors after CVB3 infection protects mice from CVB3-induced myocarditis and shall promote further studies in immunotherapies in viral acute and chronic myocarditis.

IL-9 Inhibits Viral Replication in Coxsackievirus B3-Induced Myocarditis

Correction: Th17 Cells Contribute to Viral Replication in Coxsackievirus B3-Induced Acute Viral Myocarditis

Vγ1+γδT, Early Cardiac Infiltrated Innate Population Dominantly Producing IL-4, Protect Mice Against CVB3 Myocarditis by Modulating IFNγ+ T Response

The Role of Th 17 Cells and Regulatory T Cells in Coxsackievirus B 3-Induced Myocarditis

Blockade of Interleukin-17A Protects Against Coxsackievirus B3-induced Myocarditis by Increasing COX-2/PGE2 Production in the Heart.

Neutralization of interleukin-38 exacerbates coxsackievirus B3-induced acute myocarditis in mice

Pathogenesis of coxsackievirus B3-induced myocarditis: role of macrophage migration inhibitory factor.

In Vivo Delivery of Interleukin-35 Relieves Coxsackievirus-B3-induced Viral Myocarditis by Inhibiting Th17 Cells

The Role of B Cells in Regulation of Th Cell Differentiation in Coxsackievirus B3-Induced Acute Myocarditis

The Protective Effect of Interfering TLR9-IRF5 Signaling Pathway on the Development of CVB3-induced Myocarditis.

Interleukin-6 receptor inhibition modulates the immune reaction and restores titin phosphorylation in experimental myocarditis

CTLA4-Ig Relieves Inflammation in Murine Models of Coxsackievirus B3-induced Myocarditis.

Influence of Intravenous-Immunoglobulin on T Lymphocyte Subsets, NK Cell and Some Cytokines in Mice with Experimental Viral Myocarditis

Cardiac Mir-19A/19b Was Induced and Hijacked by CVB3 to Facilitate Virus Replication Via Targeting Viral Genomic RdRp-encoding Region.

Blocking the CD40-CD40L Interaction by CD40-Ig Reduces Disease Progress in Murine Myocarditis Induced by CVB3.

Coxsackievirus B3 Infection Induced Viral Myocarditis by Regulating the Expression Pattern of Chemokines in Cardiac Myocytes.

IL-33 Enhances Macrophage M2 Polarization and Protects Mice from CVB3-induced Viral Myocarditis

Expression of Matrix Metalloproteinase-9 in Myocardium of Mice with Viral Myocarditis

Significant Reduction of Peripheral Blood Interleukin-35 and CD4+EBI3+ T Cells, Which Are Negatively Correlated with an Increase in the Plasma IL-17 and Ctni Level, in Viral Myocarditis Patients

In vivo delivery of adenoviral vector containing interleukin-17 receptor a reduces cardiac remodeling and improves myocardial function in viral myocarditis leading to dilated cardiomyopathy.

Major Group-B Enterovirus populations deleted in the noncoding 5' region of genomic RNA modulate activation of the type I interferon pathway in cardiomyocytes and induce myocarditis